Immix Biopharma Inc. IMMX
$8.80
▲ +4.32% 24H
About
Immix Biopharma Inc. is a biotechnology company engaged in developing innovative therapies for oncological and immunotherapy markets. The company focuses on creating cutting-edge treatments by leveraging its proprietary SMARxT Platform to enhance the therapeutic index of drugs. Immix Biopharma's research and developmen…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees21
TickerIMMX
Statistics
Market Cap$466.5M
Revenue (TTM)—
Net Income-$29.4M
Net Margin—
EPS$-0.89
P/E-9.65
P/S—
P/B5.09
EV/EBITDA-9.94
ROE-74.5%
Dividend Yield—
Price$8.80
Data: Twelve Data · Revenue = mcap / P/S